33 stories mentioning MRSHUpdated 10d ago
Every FINWIRES story that references MRSH, newest first.
Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.
Marsh & McLennan (MRSH) has an average rating of Hold and mean price target of $203.67, according to analysts polled by FactSet.Price: $180.12, Change: $-2.45, Percent Change: -1.34%
Marsh & McLennan (MRSH) has an average rating of Hold and mean price target of $203.67, according to analysts polled by FactSet.Price: $180.12, Change: $-2.45, Percent Change: -1.34%
Marsh & McLennan (MRSH) has an average rating of Hold and mean price target of $203.67, according to analysts polled by FactSet.Price: $180.30, Change: $-2.27, Percent Change: -1.24%
Marsh & McLennan (MRSH) has an average rating of Hold and mean price target of $203.67, according to analysts polled by FactSet.Price: $180.29, Change: $-2.28, Percent Change: -1.25%
Marsh & McLennan (MRSH) has an average rating of Hold and mean price target of $203.67, according to analysts polled by FactSet.Price: $180.04, Change: $-2.53, Percent Change: -1.39%
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target price by $8 to $200, valuing MRSH shares at 19.4x our 2026 adjusted EPS estimate of $10.33 (raised by $0.03), and at 18x our 2027 EPS estimate of $11.15 (unchanged). Our target multiple compares to MRSH's one-year average forward multiple of 19.7x and peer average of 16x. At current levels, we view the shares as fairly valued versus peer and historical averages. We note that while MRSH's Q1 revenue growth of 8% was in line with our forecast of 5% to 8% growth, results included a 3% positive currency impact and a 1% boost from acquisitions. Underlying revenue growth of 4% in Q1 is likely to be at the low end of peer averages. Also, we note MRSH shares trade at a premium to peers, but its margins have been under pressure and are lagging some peers. To that point, Q1 operating margins contracted to 23.1% from 28.4% a year ago. Weighing modest top-line growth and margin contraction with the shares' premium valuation to peers, we view the shares as fairy valued.
Financial stocks fell in late Thursday afternoon trading with the NYSE Financial Index and the State Street Financial Select Sector SPDR ETF (XLF) each easing 0.2%.The Philadelphia Housing Index dropped 0.5%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) rose 0.8%.Bitcoin (BTC-USD) gained 0.4% to $75,140, and the yield for 10-year US Treasuries advanced 2.7 basis points to 4.309%.In economic news, US initial jobless claims last week fell to 207,000 from a downwardly revised 218,000 in the previous week, compared with expectations for a smaller decrease to 213,000 in a survey of analysts by Bloomberg.US industrial production fell by 0.5% in March, compared with expectations for a 0.1% increase in a Bloomberg survey, and following an upwardly revised 0.7% increase in February.The Philadelphia Federal Reserve's monthly manufacturing index rose to 26.7 in April after increasing to 18.1 in March, compared with expectations for a decline to 10 in a survey compiled by Bloomberg.The New York Federal Reserve's services index improved to minus 14 in April from minus 22.6 in March, compared with minus 20 expected in a survey compiled by Bloomberg.In regulatory news, the US Securities and Exchange Commission is seeking public comment in support of a comprehensive review of the Consolidated Audit Trail and other such audit trails used in the regulation of the country's securities markets.In corporate news, Charles Schwab's (SCHW) Q1 results rose amid a surge in client assets, even as revenue fell short of Wall Street's estimates. The shares fell 7.7%.Goldman Sachs (GS) rates-trading business faced pressure in Q1 as Iran-related market volatility led to losses on certain positions, Reuters reported. The bank posted a 10% drop in fixed-income, currencies and commodities revenue to $4 billion, driven by weaker results in interest-rate trading, mortgages, and credit products, the report said. Goldman shares were little changed.Marsh & McLennan (MRSH) shares climbed 4.6% after the company reported Q1 adjusted net income and revenue that surpassed analysts' estimates.The National Basketball Association is in early discussions with private credit firms, including Apollo Global Management (APO), Ares Management (ARES) and Sixth Street about funding a potential European basketball league expansion, Bloomberg reported. Apollo shares rose 0.1%, and Ares fell 2.7%.
Financial stocks were lower in late Thursday afternoon trading, with the NYSE Financial Index and the State Street Financial Select Sector SPDR ETF (XLF) each easing 0.1%.The Philadelphia Housing Index was down 0.5%, and the State Street Real Estate Select Sector SPDR ETF (XLRE) was adding 0.8%.Bitcoin (BTC-USD) was increasing 0.4% to $75,140, and the yield for 10-year US Treasuries rose 2.7 basis points to 4.309%.In corporate news, Marsh & McLennan (MRSH) shares climbed 4.4% after it reported Q1 adjusted net income and revenue that surpassed analysts' consensus.
(Updates with recent stock movement in headline and first paragraph.)Marsh & McLennan (MRSH) shares were up 4.7% in afternoon trading on Thursday after the company reported Q1 adjusted net income and revenue that surpassed analysts' consensus.The company reported Q1 adjusted net income of $3.29 per diluted share, up from $3.06 a year earlier.Analysts polled by FactSet expected $3.22.Revenue for the quarter ended March 31 was $7.6 billion, up from $7.06 billion a year earlier.Analysts surveyed by FactSet expected $7.41 billion.Price: $183.14, Change: $+8.24, Percent Change: +4.71%
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Marsh & McLennan posted Q1 2026 adjusted EPS of $3.29 vs. $3.06 in the prior year, beating our $3.26 estimate and the $3.22 consensus view. Q1 revenue rose 8%, but underlying growth of 4% lagged peers, reflecting 3% currency boost and 1% acquisition contribution masking mixed organic trends across the Risk & Insurance Services and Consulting units. We remain concerned consulting demand could face headwinds from AI-driven shifts in business spending, though we expect its acquisition strategy to remain intact over the long term. The company rebranded as Marsh (ticker: MRSH) and formed a Business and Client Services unit to boost operational efficiency. Given Q1 operating margin contraction to 23.1% from 28.4%, we expect restructuring actions as the firm integrates recent deals and leverages technology improvements. We anticipate a near-term acquisition pause as the firm digests transactions amid macroeconomic uncertainty, though its margins historically lag peers despite a premium valuation to its peer group.
Marsh & McLennan (MRSH) has an average rating of Hold and mean price target of $203.62, according to analysts polled by FactSet.Price: $173.23, Change: $-0.33, Percent Change: -0.19%
GoPro (GPRO) said Monday that it is collaborating with Marsh's (MRSH) Oliver Wyman business to explore opportunities in the defense and aerospace sectors.The project will focus on evaluating addressable segments, product and technology synergies, and go-to-market strategies, GoPro said. Both companies will also work closely with defense, government, and aerospace stakeholders to ensure any services meet regulatory standards, GoPro added.Financial details of the collaboration were not provided.Shares of GoPro and Marsh rose 12% and 1.4%, respectively, in the session.Price: $0.86, Change: $+0.09, Percent Change: +12.02%
Marsh & McLennan (MRSH) has an average rating of hold and mean price target of $203.95, according to analysts polled by FactSet.Price: $170.06, Change: $+1.91, Percent Change: +1.14%
Showing 21-33 of 33
